Your browser doesn't support javascript.
loading
Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.
Wortman, B G; Astreinidou, E; Laman, M S; van der Steen-Banasik, E M; Lutgens, L C H W; Westerveld, H; Koppe, F; Slot, A; van den Berg, H A; Nowee, M E; Bijmolt, S; Stam, T C; Zwanenburg, A G; Mens, J W M; Jürgenliemk-Schulz, I M; Snyers, A; Gillham, C M; Weidner, N; Kommoss, S; Vandecasteele, K; Tomancova, V; Creutzberg, C L; Nout, R A.
Afiliación
  • Wortman BG; Department of Radiation Oncology, Leiden University Medical Centre, The Netherlands. Electronic address: b.g.wortman@lumc.nl.
  • Astreinidou E; Department of Radiation Oncology, Leiden University Medical Centre, The Netherlands.
  • Laman MS; Department of Radiation Oncology, Leiden University Medical Centre, The Netherlands.
  • van der Steen-Banasik EM; Radiotherapy Group, Arnhem, The Netherlands.
  • Lutgens LCHW; Maastricht Radiation Oncology Clinic, The Netherlands.
  • Westerveld H; Department of Radiation Oncology, Amsterdam University Medical Centres, University of Amsterdam, The Netherlands.
  • Koppe F; Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands.
  • Slot A; Radiotherapy Institute Friesland, Leeuwarden, The Netherlands.
  • van den Berg HA; Department of Radiation Oncology, Catharina Hospital Eindhoven, The Netherlands.
  • Nowee ME; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bijmolt S; Department of Radiation Oncology, University Medical Centre Groningen, The Netherlands.
  • Stam TC; Department of Radiation Oncology, Haaglanden Medical Centre, Leidschendam, The Netherlands.
  • Zwanenburg AG; Department of Radiation Oncology, Zwolle, The Netherlands.
  • Mens JWM; Department of Radiation Oncology, Erasmus MC-Cancer Institute, Rotterdam, The Netherlands.
  • Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Centre Utrecht, The Netherlands.
  • Snyers A; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Gillham CM; Department of Radiation Oncology, St Luke's Radiation Oncology Network, Dublin 6, Ireland.
  • Weidner N; Department of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University, Germany.
  • Kommoss S; Department of Women's Health, Tübingen University Hospital, Germany.
  • Vandecasteele K; Department of Radiation Oncology, Ghent University Hospital, Belgium.
  • Tomancova V; Department of Clinical Oncology, General Teaching Hospital, First Medical School, Charles University, Prague, Czech Republic.
  • Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Centre, The Netherlands.
  • Nout RA; Department of Radiation Oncology, Leiden University Medical Centre, The Netherlands.
Radiother Oncol ; 155: 160-166, 2021 02.
Article en En | MEDLINE | ID: mdl-33159971
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Braquiterapia / Neoplasias Endometriales Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Braquiterapia / Neoplasias Endometriales Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Irlanda